Salamini-Montemurri Martín, Lamas-Maceiras Mónica, Barreiro-Alonso Aida, Vizoso-Vázquez Ángel, Rodríguez-Belmonte Esther, Quindós-Varela María, Cerdán María Esperanza
EXPRELA Group, Centro de Investigacións Científicas Avanzadas (CICA), Departamento de Bioloxía, Facultade de Ciencias, INIBIC-Universidade da Coruña, Campus de A Coruña, 15071 A Coruña, Spain.
Translational Cancer Research Group, Instituto de Investigación Biomédica de A Coruña (INIBIC), Carretera del Pasaje s/n, 15006 A Coruña, Spain.
Cancers (Basel). 2020 Apr 21;12(4):1020. doi: 10.3390/cancers12041020.
Ovarian cancer is one of the most lethal gynecological malignancies worldwide because it tends to be detected late, when the disease has already spread, and prognosis is poor. In this review we aim to highlight the importance of long non-coding RNAs (lncRNAs) in diagnosis, prognosis and treatment choice, to make progress towards increasingly personalized medicine in this malignancy. We review the effects of lncRNAs associated with ovarian cancer in the context of cancer hallmarks. We also discuss the molecular mechanisms by which lncRNAs become involved in cellular physiology; the onset, development and progression of ovarian cancer; and lncRNAs' regulatory mechanisms at the transcriptional, post-transcriptional and post-translational stages of gene expression. Finally, we compile a series of online resources useful for the study of lncRNAs, especially in the context of ovarian cancer. Future work required in the field is also discussed along with some concluding remarks.
卵巢癌是全球最致命的妇科恶性肿瘤之一,因为它往往在疾病已经扩散且预后较差时才被发现。在本综述中,我们旨在强调长链非编码RNA(lncRNA)在诊断、预后和治疗选择中的重要性,以推动这种恶性肿瘤的个性化医疗取得进展。我们在癌症特征的背景下综述了与卵巢癌相关的lncRNA的作用。我们还讨论了lncRNA参与细胞生理学的分子机制;卵巢癌的发生、发展和进展;以及lncRNA在基因表达的转录、转录后和翻译后阶段的调控机制。最后,我们汇编了一系列有助于lncRNA研究的在线资源,特别是在卵巢癌背景下的资源。还讨论了该领域未来需要开展的工作以及一些总结性评论。